HCW Biologics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
HCW Biologics Inc. (HCWB) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 44.19 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-03-31
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 44.19K shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 44.60K shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed 1.78M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 44.48K shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed 1.78M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1.87M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2025-12-31 | 44.19K shares 10-K · filed 2026-03-31 | |
| 2024-12-31 | 44.60K shares 10-K · filed 2026-03-31 | 1.78M shares 10-K · filed 2025-03-28 |
| 2023-12-31 | 44.48K shares 10-K · filed 2026-03-31 | 1.78M shares 10-K · filed 2024-04-01 |
| 2022-12-31 | 1.87M shares 10-K · filed 2025-03-28 | |
| 2021-12-31 | 1.77M shares 10-K/A · filed 2024-05-15 | |
| 2020-12-31 | 742.05K shares 10-K · filed 2023-03-28 | |
| 2019-12-31 | 586.66K shares 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |